2
Total deals
$1.4B
Total value
$707.5M
Avg deal
$1.1B
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Araris Biotech
Araris Biotech is a biotechnology company that develops antibody-drug conjugates…
|
2025-03-17 | Acquisition | Pending | $1.1B | Deal → |
| 2 |
Cullinan Pearl
Cullinan Pearl develops an orally available tyrosine kinase inhibitor to target …
|
2022-05-12 | Acquisition | Complete | $275.0M | Deal → |